Qifu Li

Prof. Qifu Li

Key Laboratory of Tropical Diseases and Translational Medicine of Ministry of Education & Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou, China
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
SCShuang Chen
Shuang Chen
YCYongmin Chen
Yongmin Chen
YZYukang Zhang
Yukang Zhang
XKXi Kuang
Xi Kuang
YLYan Liu
Yan Liu
Qifu LiQifu Li
Qifu Li
Epilepsy is a disease characterized by recurrent, episodic, and transient central nervous system (CNS) dysfunction resulting from an excessive synchronous discharge of brain neurons. It is characterized by diverse etiology, complex pathogenesis, and difficult treatment. In addition, most epileptic patients exhibit social cognitive impairment and psychological impairment. Iron is an essential trace element for human growth and development and is also involved in a variety of redox reactions in organisms. However, abnormal iron metabolism is associated with several neurological disorders, including hemorrhagic post-stroke epilepsy and post-traumatic epilepsy (PTE). Moreover, ferroptosis is also considered a new form of regulation of cell death, which is attributed to severe lipid peroxidation caused by the production of reactive oxygen species (ROS) and iron overload found in various neurological diseases, including epilepsy. Therefore, this review summarizes the study on iron metabolism and ferroptosis in epilepsy, in order to elucidate the correlation between iron and epilepsy. It also provides a novel method for the treatment, prevention, and research of epilepsy, to control epileptic seizures and reduce nerve injury after the epileptic seizure.

17 October 2016 in Proteomics
Verified
Journal Article
Closed access
PDF file
ZHZhao Huang
Zhao Huang
LMLinguang Ma
Linguang Ma
CHCanhua Huang
Canhua Huang
Qifu LiQifu Li
Qifu Li
ENEdouard Nice
Edouard Nice

30 June 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
XBXin-Yu Ben
Xin-Yu Ben
YWYa-Ru Wang
Ya-Ru Wang
HZHui-Hui Zheng
Hui-Hui Zheng
DLDe-Xian Li
De-Xian Li
RRRui Ren
Rui Ren
XYXinan Yi
Xinan Yi
Our general purpose was to provide a theoretical and practical foundation for the use of exosomes (EXOs) that have high levels of CD47 as stable and efficient drug carriers. Thus, we prepared EXOs from adipose tissue-derived mesenchymal stromal cells (ADMSCs) that had high levels of CD47 (EXOsCD47) and control EXOs (without CD47), and then compared their immune escapein vivoand their resistance to phagocytosisin vitro. Nanoflow cytometry was used to determine the CD47 level in these EXOs, and the amount of EXOsCD47that remained in rat plasma at 3 h after intraperitoneal injection. Phagocytosis of the EXOs was also determined usingin vitrorat macrophage bone marrow (RMA-BM) experiments. Ourin vitroresults showed that macrophages ingested significantly more control EXOs than EXOsCD47(p< 0.01), with confirmation by ultra-high-definition laser confocal microscopy. Consistently, ourin vivoresults showed that rats had 1.377-fold better retention of EXOsCD47than control EXOs (p< 0.01). These results confirmed that these engineered EXOsCD47had improved immune escape. Our results therefore verified that EXOsCD47had increased immune evasion relative to control EXOs, and have potential for use as drug carriers.

17 July 2023 in Small
Verified
Journal Article
Closed access
JLJiantang Liang
Jiantang Liang
LLLei Li
Lei Li
HTHailong Tian
Hailong Tian
ZWZhihan Wang
Zhihan Wang
GLGuowen Liu
Guowen Liu
Qifu LiQifu Li
Qifu Li

25 July 2018 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
XWXue‑Yan Wen
Xue‑Yan Wen
YCYong‑Min Chen
Yong‑Min Chen
LYLi‑Li Yu
Li‑Li Yu
SWShu‑Rong Wang
Shu‑Rong Wang
HZHong‑Bo Zheng
Hong‑Bo Zheng
QLQi‑Fu Li
Qi‑Fu Li
Atrial myxoma is the most common type of primary cardiac tumor and it is closely associated with stroke in adults. Early diagnosis and treatment of atrial myxomas is essential for the prevention of embolic events. The aim of the present study was to assess neurological complications associated with atrial myxoma. The neurological signs of atrial myxoma were retrospectively assessed in individuals who underwent treatment at West China Hospital (Chengdu, China) and The Affiliated Hospital of Hainan Medical University (Haikou, China), between March 2003 and February 2015. A total of 130 patients with atrial myxoma were included and 22 (17%) exhibited neurologic signs. These patients were aged 39.9±12.6 years (range, 13‑78 years) and there were 13 female and 9 male patients. Ischemic cerebral infarct constituted the dominant clinical symptom (68.2%) and 3 patients exhibited concomitant cardiac manifestations. Atrial myxoma was diagnosed by echocardiography in all patients. Irregular surface of atrial myxomas was associated with a high risk of embolic events. The patients with myxoma successfully underwent surgery with no mortality recorded. In conclusion, atrial myxomas frequently manifest as cerebral infarction in individuals without cardiovascular risk factors. These tumors more commonly affect the middle cerebral artery. Irregular surface of myxomas appears to be associated with embolic events. Echocardiography may improve the diagnosis and early treatment of atrial myxomas.

8 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YWYan Wang
Yan Wang
ZXZhongyv Xiong
Zhongyv Xiong
CLChang Li
Chang Li
DLDong Liu
Dong Liu
XLXiaogang Li
Xiaogang Li
YLYoubin Li
Youbin Li
Aloesone is a major metabolic compound in Aloe vera, which has been widely used as a food source and therapeutic agent in several countries. Our recent study demonstrated that aloesone has anti-epileptic effects on glutamate-induced neuronal injury by suppressing the production of reactive oxygen species (ROS). Unless ROS are naturally neutralized by the endogenous antioxidant system, they lead to the activation of inflammation, polarization, and apoptosis. This study aimed to identify the multiple beneficial effects of aloesone and explore its molecular mechanism in macrophages. Hence, the murine macrophage cell line RAW264.7 was pretreated with aloesone and then exposed to lipopolysaccharides (LPS). The results demonstrated that aloesone, within a dosage range of 0.1–100 µM, dramatically decreased the LPS-induced elevation of ROS production, reduced nitric oxide (NO) release, inhibited the M1 polarization of RAW264.7 cells, and prevented cells from entering the LPS-induced early and late phases of apoptosis in a dose-dependent manner. Simultaneously, aloesone significantly decreased the mRNA expression of inflammation-related genes (iNOS, IL-1ꞵ, TNF-α) and increased the expression of antioxidant enzymes (Gpx-1 and SOD-1). The core genes HSP90AA1, Stat3, Mapk1, mTOR, Fyn, Ptk2b, and Lck were closely related to these beneficial effects of aloesone. Furthermore, immunofluorescence staining and flow cytometry data confirmed that aloesone significantly repressed the activation of mTOR, p-mTOR, and HIF-1α induced by LPS and inhibited the protein expression of TLR4, which is the target of LPS. In conclusion, aloesone demonstrated multiple protective effects against LPS-induced oxidative stress, inflammation, M1 polarization, and apoptosis in macrophages, suggesting its potential as a prodrug.